- Report
- November 2024
- 799 Pages
Global
From €4368EUR$4,799USD£3,710GBP
- Report
- March 2025
- 120 Pages
Global
From €2230EUR$2,450USD£1,894GBP
€4460EUR$4,900USD£3,788GBP
- Report
- October 2024
- 184 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- October 2024
- 182 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- December 2024
- 180 Pages
Global
From €5416EUR$5,950USD£4,600GBP
- Report
- April 2025
- 172 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- March 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- November 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,749GBP
- Report
- December 2024
- 150 Pages
Global
From €3056EUR$3,358USD£2,596GBP
€3595EUR$3,950USD£3,054GBP
- Report
- November 2024
- 185 Pages
Global
From €4546EUR$4,995USD£3,861GBP
- Report
- June 2024
- 68 Pages
Europe
From €2685EUR$2,950USD£2,281GBP
- Report
- October 2024
- 70 Pages
North America
From €865EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
Asia Pacific
From €865EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
Latin America
From €865EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
United States
From €865EUR$950USD£734GBP
- Report
- August 2024
- 66 Pages
Global
From €569EUR$625USD£483GBP
€1138EUR$1,250USD£966GBP
- Report
- October 2024
- 187 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- October 2024
- 191 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- January 2025
- 163 Pages
Global
From €2721EUR$2,990USD£2,311GBP

The Bio CMO market is a subset of the biopharmaceutical industry, which focuses on the production of biopharmaceuticals. Bio CMOs provide contract manufacturing services to biopharmaceutical companies, such as drug development, clinical trial materials, and commercial production. These services are typically tailored to the specific needs of the customer, and can include process development, analytical services, and quality control. Bio CMOs are also responsible for the production of biopharmaceuticals, including the manufacture of active pharmaceutical ingredients (APIs) and the formulation of finished dosage forms.
Bio CMOs are an important part of the biopharmaceutical industry, as they provide the necessary services to enable the development and production of biopharmaceuticals. Examples of companies in the Bio CMO market include Lonza, Boehringer Ingelheim, Catalent, and Patheon. Show Less Read more